Suppr超能文献

应激性红细胞生成的药效学分析:绵羊双放血后促红细胞生成素受体库大小的变化。

Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep.

机构信息

Division of Pharmaceutics, College of Pharmacy, The University of Iowa, Iowa City, USA.

出版信息

Biopharm Drug Dispos. 2011 Apr;32(3):131-9. doi: 10.1002/bdd.743. Epub 2011 Jan 10.

Abstract

A feedback receptor regulation model was incorporated into a pharmacodynamic model to describe the stimulation of hemoglobin (Hb) production by endogenous erythropoietin (EPO). The model considers the dynamic changes that take place in the EPO receptor (EPOR) pool under phlebotomy-induced anemia. Using a (125)I-rhEPO tracer the EPO clearance changes are evaluated longitudinally prior to and following phlebotomy-induced anemia indirectly to evaluate changes in the EPOR pool size, which has been shown to be linearly related to the clearance. The proposed model simultaneously captures the general behavior of temporal changes in Hb relative to EPO plasma clearance in five lambs (r = 0.95), while accounting for the confounding variables of phlebotomy and changes in the blood volume in the growing animals. The results indicate that under anemia the EPOR pool size is up-regulated by a factor of nearly two over baseline and that the lowest and highest EPOR pool sizes differ by a factor of approximately four. The kinetic model developed and the data-driven mechanism proposed serves as a starting point for developing an optimal EPO dosing algorithm for the treatment of neonatal anemia.

摘要

将反馈受体调节模型纳入药效动力学模型,以描述内源性促红细胞生成素(EPO)对血红蛋白(Hb)生成的刺激作用。该模型考虑了在放血诱导性贫血下 EPO 受体(EPOR)池发生的动态变化。使用(125)I-rhEPO 示踪剂,在放血诱导性贫血之前和之后进行纵向评估 EPO 清除率的变化,间接评估 EPOR 池大小的变化,已经证明 EPOR 池大小与清除率呈线性相关。该模型同时捕捉了五只羔羊中 Hb 相对于 EPO 血浆清除率的时间变化的一般行为(r = 0.95),同时考虑了放血和生长中动物血液量变化的混杂变量。结果表明,在贫血情况下,EPOR 池大小相对于基线上调了近两倍,最低和最高 EPOR 池大小相差约四倍。所开发的动力学模型和提出的数据驱动机制为开发用于治疗新生儿贫血的最佳 EPO 给药算法提供了起点。

相似文献

2
Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.
Exp Hematol. 2001 Apr;29(4):425-31. doi: 10.1016/s0301-472x(01)00614-2.
3
Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy.
Drug Metab Dispos. 2011 Jul;39(7):1214-20. doi: 10.1124/dmd.110.036855. Epub 2011 Apr 1.
5
Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia.
J Pharmacol Exp Ther. 2004 Jul;310(1):202-8. doi: 10.1124/jpet.104.066027. Epub 2004 Feb 26.
7
Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.
Am J Physiol Regul Integr Comp Physiol. 2013 May 1;304(9):R772-81. doi: 10.1152/ajpregu.00173.2012. Epub 2013 Mar 13.
8
Increased erythropoietin elimination in fetal sheep following chronic phlebotomy.
Pharm Res. 2007 Sep;24(9):1653-9. doi: 10.1007/s11095-007-9295-3. Epub 2007 Apr 25.
9
Erythropoietin production rate in phlebotomy-induced acute anemia.
Biopharm Drug Dispos. 2004 Dec;25(9):389-97. doi: 10.1002/bdd.424.

引用本文的文献

2
A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs.
AAPS J. 2015 Sep;17(5):1246-54. doi: 10.1208/s12248-015-9784-y. Epub 2015 May 28.
3
Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.
Am J Physiol Regul Integr Comp Physiol. 2013 May 1;304(9):R772-81. doi: 10.1152/ajpregu.00173.2012. Epub 2013 Mar 13.

本文引用的文献

1
Covering a broad dynamic range: information processing at the erythropoietin receptor.
Science. 2010 Jun 11;328(5984):1404-8. doi: 10.1126/science.1184913. Epub 2010 May 20.
3
Dosing in children.
Clin Pharmacol Ther. 2010 Mar;87(3):367-70. doi: 10.1038/clpt.2009.262. Epub 2010 Jan 20.
4
Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants.
J Pharmacol Exp Ther. 2010 Jan;332(1):229-37. doi: 10.1124/jpet.109.159905. Epub 2009 Oct 6.
5
Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia.
Pediatr Int. 2009 Feb;51(1):25-32. doi: 10.1111/j.1442-200X.2008.02648.x.
6
Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.
J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):285-323. doi: 10.1007/s10928-008-9089-1. Epub 2008 Jun 14.
7
Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers.
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):637-45. doi: 10.1007/s00210-007-0225-z. Epub 2007 Dec 11.
8
Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers.
J Clin Pharmacol. 2008 Jan;48(1):43-52. doi: 10.1177/0091270007309702. Epub 2007 Nov 19.
9
Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep.
J Pharmacokinet Pharmacodyn. 2007 Aug;34(4):519-47. doi: 10.1007/s10928-007-9056-2. Epub 2007 May 22.
10
Increased erythropoietin elimination in fetal sheep following chronic phlebotomy.
Pharm Res. 2007 Sep;24(9):1653-9. doi: 10.1007/s11095-007-9295-3. Epub 2007 Apr 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验